KAPIOLANI MED CTR FOR WOMEN & CHILDR — History
CCN 123300 | 3-year financial timeline | COVID resilience: 72/100
🛡️ Public data only — no PHI permitted on this instance.
$437M
Latest Revenue (FY2022)
+9.3%
Revenue CAGR (3yr)
11.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $366M | $404M | $437M | +8.2% | +9.3% |
| Operating Expenses | $344M | $370M | $386M | +4.3% | +5.9% |
| Operating Margin | 6.1% | 8.6% | 11.9% | +38.2% | +39.0% |
| Net Income | $23M | $35M | $52M | +49.5% | +51.8% |
| Licensed Beds | 253 | 253 | 253 | +0.0% | +0.0% |
| Total Patient Days | 59,397 | 64,075 | 66,473 | +3.7% | +5.8% |
| Medicare Day % | 0% | 0% | 0% | -29.0% | +8.6% |
| Medicaid Day % | 0% | 0% | 0% | +21.2% | -18.4% |
COVID Impact & Recovery
Resilience Score: 72/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +19.4% ($366M → $437M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.3%
This Hospital
+7.6%
State Avg
Latest Margin
11.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $473M | 14.7% |
| FY2024 (proj) | $509M | 17.6% |
| FY2025 (proj) | $544M | 20.5% |